BGB-3111-309
Recruiting
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
BeOne Study ID
ClinicalTrials.gov ID
EudraCT Number
China Drug Trials ID
Study Overview
Sex:
All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents